ROC Holdings SPV II, LP

New Filing

CIK: 0002082735·Biotechnology·DELAWARE·Filed: Aug 21, 2025

Total Offering

Indefinite

Amount Sold

$3,650,000

Investors

16

First Sale

May 15, 2024

Offering Details

Type: Pooled Investment Fund
Exemptions: Rule 506(b), Section 3(c), Section 3(c)(7)
Entity Type: Limited Partnership
Year Incorporated: 2024
Non-Accredited Investors: No

Related Persons

Name	Role
Matthew Smith	Related Person
James Dahlman	Related Person

Company

ROC Holdings SPV II, LP

1630 COLUMBIA ROAD NW, APT. 418

WASHINGTON, DC, 20009

917.912.2289

SEC Filing

0001814554-25-000086

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.